Needham Revises Archer Aviation's Price Target to $9
Money

Needham Revises Archer Aviation's Price Target to $9

authorBy Mr. Money Mustache
DateMar 10, 2026
Read time2 min

Needham & Company has recently lowered its price target for Archer Aviation Inc. (ACHR) to $9 from $10, yet it maintains a Buy rating for the stock. This adjustment comes after the company's solid fourth-quarter results, which showcased a healthy financial standing and significant strides in its aircraft development. Archer Aviation's focus on electric vertical take-off and landing (eVTOL) technology for urban air mobility is positioning it as a key player in the evolving advanced air mobility market, with plans for piloted operations and passenger flights in the near future.

Archer Aviation reported impressive fourth-quarter results, revealing a record $2.0 billion in total liquidity. This substantial capital is expected to fuel the company's commercialization efforts, scale up manufacturing, and support strategic investments. Analysts view these financial strengths as crucial for the company's long-term objectives, despite potential operational hurdles in the upcoming year.

The company is actively expanding its flight testing initiatives and boosting the production of its Midnight aircraft. The Midnight aircraft is currently undergoing vertical take-off and landing flight tests, a critical phase before transitioning to full piloted flights. These developments are integral to Archer's participation in the government-backed eVTOL Integration Pilot Program, with piloted operations slated to commence later this year and passenger-carrying flights targeted for 2026.

Archer Aviation, established in 2018 and based in San Jose, California, specializes in developing eVTOL aircraft for urban air mobility and short-distance travel. The company's comprehensive flight test schedule and strategic commercialization plan are designed to solidify its presence in the burgeoning advanced air mobility sector, promising transformative changes in regional transportation.

Archer Aviation's continued progress in flight testing and strategic market positioning underscore its commitment to pioneering urban air mobility solutions. The company's financial stability and innovative aircraft development initiatives are expected to drive its growth and influence in the advanced air mobility landscape, offering a glimpse into the future of air travel.

More Articles
CFTC Chair Declares US as 'Crypto Capital,' Unveils New Guidance
CFTC Chairman Michael Selig has proclaimed the United States as the "crypto capital of the world," introducing new guidelines for non-custodial software developers, a crypto asset taxonomy, and Project Crypto to resolve inter-agency conflicts. He also criticized Dodd-Frank's impact and promoted prediction markets, crediting former President Trump for fostering a crypto-friendly environment.
By Scott PapeMar 10, 2026
Analyst Firms Adjust Price Targets for BigBear.ai Amidst Q4 Performance and Future Outlook
Cantor Fitzgerald and H.C. Wainwright have revised their price targets for BigBear.ai Holdings, Inc. (BBAI) following its fourth-quarter earnings release. While Cantor Fitzgerald lowered its target to $5 due to a revenue decline, H.C. Wainwright maintained a 'Buy' rating, adjusting its target to $6, citing improved financial flexibility. The company reported a narrower-than-expected loss per share and highlighted strategic advancements in debt reduction, international expansion, and acquisitions, positioning itself for future growth with government AI initiatives.
By Mr. Money MustacheMar 10, 2026
NexGel to Acquire Regenerative Biomaterial Portfolio from Celularity, Projects Triple Revenue
NexGel Inc. is set to acquire a regenerative biomaterial portfolio from Celularity, Inc., a strategic move expected to nearly triple NexGel's annual revenue to approximately $35 million in 2026. This acquisition, along with significant financing, is poised to make the company immediately profitable and a more substantial player in the medical technology sector. The portfolio includes products with over a decade of clinical use, offering stable revenue and future growth prospects through additional product filings.
By Scott PapeMar 10, 2026
Stem, Inc. Reports Reduced Net Loss and German Expansion
Stem, Inc. (NYSE:STEM) announced its fourth-quarter earnings, revealing a narrowed net loss despite a revenue decrease. The energy technology company also secured a significant agreement to deploy its energy management system in Germany, marking a strategic international expansion.
By Natalie PaceMar 10, 2026
Pzena Global Small Cap Focused Value Strategy Maintains Confidence in Advance Auto Parts
Pzena Global Small Cap Focused Value Strategy recently released its fourth-quarter 2025 commentary, where it reaffirmed its confidence in Advance Auto Parts (AAP). Despite the portfolio's underperformance against the MSCI World Small Cap Index during this period, Pzena views AAP's short-term challenges as transient and remains optimistic about the company's turnaround efforts. This article delves into the reasons behind Pzena's sustained belief in AAP, examining the company's market position and future prospects.
By Chika UwazieMar 10, 2026